Koten, K., Hirohata, S., Miyoshi, T., et al. (2008) Serum Interferon-Gamma-Inducible Protein 10 Level Was Increased in Myocardial Infarction Patients, and Negatively Correlated with Infarct Size. Clinical Biochemistry, 41, 30-37.
http://dx.doi.org/10.1016/j.clinbiochem.2007.10.001

has been cited by the following article:

• TITLE: Massive Thromboembolism from an Abdominal Aortic Aneurysm after Successful Thrombolysis for an Acute Myocardial Infarction

  AUTHORS: Fernando Luiz de Melo Bernardi, Paulo Cury Rezende, Cibele Larrosa Garzillo, Eduardo Gomes Lima, Diogo Arantes Behling Pereira da Luz, Vera Demarchi Aiello, Whady Hueb

  KEYWORDS: Thromboembolism, Abdominal Aortic Aneurysm, Fibrinolysis, Myocardial Infarction

  JOURNAL NAME: Case Reports in Clinical Medicine, Vol.4 No.2, February 2, 2015

  ABSTRACT: Thrombolytic therapy is indicated to the treatment of patients with ST-elevation myocardial infarction or pulmonary embolism. Its indication should especially consider the risk of bleeding, but other complications might pose harm to patients. Although rarely reported, fibrinolysis can trigger thromboembolic phenomena from emboligenic sources such as aortic aneurysms. Clinicians should be aware of this life-threatening complication. In this case report, we present one patient admitted due to a ST-segment elevation acute myocardial infarction successfully treated with fibrinolytic treatment, but who evolved with a massive microembolism from an abdominal aortic aneurysm. Despite intensive medical care, the patient evolved with multiorganic failure due to distal microembolism to the guts and lower limbs, severe rhabdomyolysis and ultimately to death. In this challenging case, clinical, anatomical and histopathologic features are presented and discussed.